Open menu
Paytm Money logo
search-placeholder
search
Mutual Fund Details
search-placeholder
search
Nippon India Mutual Fund

Nippon India Pharma Fund Direct-Growth

NAV
returns change indicator
149.9470
as on 17 Oct 2019, 11:35 PM
0.4473(0.30%)
Last Change
loaderloader

Start SIP in this Mutual Fund

Min SIP Amount
100
Suggested Date
11th of Every Month
Invest via SIP

Investment Performance

would have given a return of
110,871
star
121,647
star
98,660
star
101,257
star
Bank Account
Fixed Deposit
Regular Mutual Fund
This Fund on Paytm Money
This Mutual Fund
1,256
Profit (absolute return)
1.26%
in the last
1m
3m
1y
3y
5y
max
+1% Higher Returns
With Direct Plans on Paytm Money

Investment Returns

In the last 3 months
1.01%
In the last 6 months
7.39%
In the last 1 year
7.17%
In the last 3 years
1.26%
In the last 5 years
27.53%
In the last 10 years
NA
Absolute Returns
CAGR

Scheme Riskometer

low
low
moderately low
moderately low
moderate
moderate
moderately high
moderately high
high
high
indicator
Investors understand that their principal will be at high risk

Scheme Information

Nippon India Pharma Fund Direct-Growth
Nippon India Pharma Fund Direct-Growth
as of 17 Oct 2019, 11:35 PM
2,377.03 Cr
Scheme Asset Size
Fund Type
Open-End
Exit Load
Exit load of 1% if redeemed within 1 year
1.36%
Expense Ratio
Plan
Growth
0.56%
Cash Holding
Benchmark
S&P BSE Healthcare Total Return Index
Scheme Document
Benchmark
S&P BSE Healthcare Total Return Index
Exit Load
Exit load of 1% if redeemed within 1 year
Scheme Document

Sectors Holding in this Mutual Fund

as on 31 Aug 2019
Sort By
Healthcare
99.78%
2,371.80 Cr
Cash Holding
0.16%
3.80 Cr

Companies Holding in this Mutual Fund

as on 31 Aug 2019
Sort By
Sun Pharmaceutical Inds. Ltd.
10.86%
258.14 Cr
Divi's Laboratories Ltd.
10.71%
254.58 Cr
Aurobindo Pharma Ltd.
8.34%
198.24 Cr
Cipla Ltd.
7.85%
186.60 Cr
Dr. Reddy's Laboratories Ltd.
7.53%
178.99 Cr
Abbott India Ltd.
7.13%
169.48 Cr
Lupin Ltd.
7.06%
167.82 Cr
Syngene International Ltd.
6.67%
158.55 Cr
Fortis Healthcare (India) Ltd
6.61%
157.12 Cr
Alkem Laboratories Ltd.
5.51%
130.97 Cr
View All
View All

About Nippon India Pharma Fund Direct-Growth

Nippon India Pharma Fund Direct-Growth is a Equity mutual fund scheme from Nippon India Mutual Fund. This scheme was launched on 01 Jan 2013 and is currently managed by its fund manager Sailesh Raj Bhan. It has an AUM of ₹2,377.03 Crores and the latest NAV decalared is ₹149.947 as on 17 Oct 2019 at 11:35 pm.
Nippon India Pharma Fund Direct-Growth scheme return performance in last 1 year is -7.17%, in last 3 years is 1.26% and 114.63% since scheme launch. The min. SIP amount to invest in this scheme is ₹100.

Scheme Details

AUM:2,377.03 Cr
Category:Equity: Sectoral-Pharma
Launch Date:01 Jan 2013
Fund Type:Open-End

Scheme Objective

The scheme seeks to generate consistent returns by investing in equity / equity related or fixed income securities of pharma and other associated companies.

AMC Information

Nippon India Mutual Fund
Nippon India Mutual Fund
View AMC Details
193,997.61 Cr
AUM
192
Schemes
Address
Address
Reliance Centre, 7th Floor, South WingOff Western Express HighwaySantacruz (East)400055
Phone Number
Phone Number
Phone : 022-68334800 / 18602660111
Fax : 022-33037662